Michelle C. Salazar

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

20h-index1.2kcitations57works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(15), Lung Cancer Diagnosis and Treatment(14), Cancer Immunotherapy and Biomarkers(12), Cancer Cells and Metastasis(8), Lung Cancer Research Studies(8)

Publications57 total

Research and Development in Surgical Practices
2026
Lung Cancers in Never-Smokers
Surgical Oncology Clinics of North America·2025
Association of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer
Cancer Medicine·2024· 5 citedOpen Access
Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional Study
JMIR Cancer·2023· 5 citedOpen Access
Why Are There So Few Women Medical School Deans? Debunking the Myth That Shorter Tenures Drive Disparities
Academic Medicine·2023· 6 cited
Table S1 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Figure S3 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Table S1 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Figure S2 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Figure S1 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Figure S1 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Data from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Figure S2 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Figure S3 from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Data from Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
2023Open Access
Telehealth Availability for Cancer Care During the COVID-19 Pandemic: Cross-Sectional Study (Preprint)
2023Open Access
Do as I Say, Not as I Do: Resident Physicians’ Approach to Seeking Care During Times of Acute Physical Illness
Journal of the American College of Surgeons·2022
Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis
JAMA Network Open·2022· 48 citedOpen Access
Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US
JAMA Network Open·2022· 36 citedOpen Access
Appendiceal Cancer in the National Cancer Database: Increasing Frequency, Decreasing Age, and Shifting Histology
Journal of the American College of Surgeons·2022· 27 cited
page 1 of 3Next →

Frequent Co-authors

Daniel J. Boffa(27), Justin D. Blasberg(14), Daniel J. Boffa(13), Jessica R. Hoag(13), Joshua E. Rosen(12), Frank C. Detterbeck(12), Maureen Canavan(12), Brian N. Arnold(11), Anthony W. Kim(11), Daniel C. Thomas(8), Ryon P. Graf(8), Rachel Krupa(8), Jessica Louw(8), Lyndsey Dugan(8), Yipeng Wang(8), Marisa Magaña(8), Samir Makani(8), Ryan Dittamore(8), Jorge J. Nieva(8), Mark Landers(7)